ANALYSIS OF A RANGE OF ABDOMINAL AND BOWEL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA REPORTING INADEQUATE SYMPTOM CONTROL WITH LOPERAMIDE: RESULTS FROM ELUXADOLINE CLINICAL TRIALS

被引：0
|
作者：
Brenner, Darren M.
Sayuk, Gregory S.
Saeed, Mazen
Janiszewski, Peter
Liu, Louis W.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1327
引用
收藏
页码：S851 / S851
页数：1
相关论文
共 50 条
  • [21] Eluxadoline for the treatment of irritable bowel syndrome with diarrhea (IBS-D): results of two randomized, double-blind, placebo-controlled Phase 3 clinical trials
    Covington, Paul
    PHARMACOTHERAPY, 2015, 35 (11): : E189 - E189
  • [22] Abdominal Bloating in Patients With Irritable Bowel Syndrome: Characterization of Clinical Symptoms, Psychological Factors and Associated Comorbidities
    Hod, Keren
    Ringel-Kulka, Tamar
    Van Tilburg, Miranda A.
    Ringel, Yehuda
    GASTROENTEROLOGY, 2014, 146 (05) : S532 - S532
  • [23] RIFAXIMIN SIGNIFICANTLY IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A POOLED ANALYSIS OF THREE PHASE 3 TRIALS
    Schoenfeld, Philip S.
    Brenner, Darren M.
    Pichetshote, Nipaporn
    Heimanson, Zeev
    Lacy, Brian E.
    GASTROENTEROLOGY, 2021, 160 (06) : S281 - S281
  • [24] Time to Relief of Key Abdominal and Bowel Symptoms of Irritable Bowel Syndrome with Constipation: A Post-Hoc Analysis of Randomized Controlled Trials of Linaclotide
    Brenner, Darren M.
    Lacy, Brian E.
    Ford, Alexander C.
    Bartolini, Wilmin
    Wu, James
    Shea, Elizabeth P.
    Bochenek, Wieslaw
    Boinpally, Ramesh
    Almansa, Cristina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S228 - S228
  • [25] Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety
    Lembo, Anthony
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    McIntyre, Gail
    Almenoff, June
    Covington, Paul S.
    GASTROENTEROLOGY, 2014, 146 (05) : S159 - S159
  • [26] Effectiveness of recruitment in clinical trials: An analysis of methods used in a trial for irritable bowel syndrome patients
    Feman, Siu Ping Chin
    Nguyen, Long I.
    Quilty, Mary T.
    Kerr, Catherine E.
    Nam, Bong Hyun
    Conboy, Lisa A.
    Singer, Joyce P.
    Park, Min
    Lembo, Anthony J.
    Kaptchuk, Ted J.
    Davis, Roger B.
    CONTEMPORARY CLINICAL TRIALS, 2008, 29 (02) : 241 - 251
  • [27] UNDERSTANDING SYMPTOM BURDEN AND ATTITUDES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA: RESULTS FROM A PATIENT SURVEY
    Tornblom, H.
    Emmanuel, A.
    Goosey, R.
    Wiseman, G.
    Baker, S.
    GUT, 2017, 66 : A265 - A266
  • [28] Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials
    Longstreth, GF
    Hawkey, CJ
    Mayer, EA
    Jones, RH
    Naesdal, J
    Wilson, IK
    Peacock, RA
    Wiklund, IK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (07) : 959 - 964
  • [29] Improvement in abdominal symptoms rated as most severe by patients with Irritable Bowel Syndrome with Constipation (IBS-C): Results from two phase 3 trials of linaclotide
    Rao, S.
    Quigley, E.
    Shiff, S.
    Lavins, B.
    Kurtz, C.
    Schneier, H.
    Currie, M.
    Johnston, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 27 - 27
  • [30] A Tritordeum-Based Diet for Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Effects on Abdominal Bloating and Psychological Symptoms
    Riezzo, Giuseppe
    Prospero, Laura
    Orlando, Antonella
    Linsalata, Michele
    D'Attoma, Benedetta
    Ignazzi, Antonia
    Giannelli, Gianluigi
    Russo, Francesco
    NUTRIENTS, 2023, 15 (06)
12345